SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2025 on March 3, 2026

Group 1 - SOPHiA GENETICS will announce its financial results for Q4 and full year 2025 on March 3, 2026, before U.S. markets open [1] - A conference call to discuss the financial results and business outlook will take place at 8:00 a.m. EDT / 2:00 p.m. CET on the same day [1] - The call will be available via live webcast and a replay will be accessible on the company's Investor Relations website [1] Group 2 - SOPHiA GENETICS is a leader in AI-driven precision medicine, focusing on expanding access to data-driven medicine for cancer and rare disorders [1] - The company utilizes the SOPHiA DDM™ Platform, a cloud-native platform that analyzes complex multimodal data to provide actionable insights [1] - The platform integrates various data types, including genomics, radiomics, clinical, biological, and digital pathology data [1]